Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $7.41 Million - $13.1 Million
-800,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $6.03 Million - $14.6 Million
800,000 New
800,000 $13.4 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track 12 West Capital Management LP Portfolio

Follow 12 West Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on 12 West Capital Management LP with notifications on news.